Report of the ISHLT Working Group on Primary Lung Graft Dysfunction part V: predictors and outcomes.
about
Plasma cytokines and chemokines in primary graft dysfunction post-lung transplantation.Activation of complement factor B contributes to murine and human myocardial ischemia/reperfusion injury.Construct validity of the definition of primary graft dysfunction after lung transplantation.Elevated plasma angiopoietin-2 levels and primary graft dysfunction after lung transplantation.Elevated pulmonary artery pressure is a risk factor for primary graft dysfunction following lung transplantation for idiopathic pulmonary fibrosis.Elevated plasma clara cell secretory protein concentration is associated with high-grade primary graft dysfunctionThe role of donor chronic alcohol abuse in the development of primary graft dysfunction in lung transplant recipients.Neutrophil extracellular traps are pathogenic in primary graft dysfunction after lung transplantation.Association of protein C and type 1 plasminogen activator inhibitor with primary graft dysfunction.Variation in PTX3 is associated with primary graft dysfunction after lung transplantation.The relationship between plasma lipid peroxidation products and primary graft dysfunction after lung transplantation is modified by donor smoking and reperfusion hyperoxia.Pediatric lung transplantation: perspectives for the pathologist.Graft dysfunction immediately after reperfusion predicts short-term outcomes in living-donor lobar lung transplantation but not in cadaveric lung transplantation.Plasma levels of receptor for advanced glycation end products, blood transfusion, and risk of primary graft dysfunction.Primary graft dysfunction.Genetic variation in the prostaglandin E2 pathway is associated with primary graft dysfunction.Five-year update on the mouse model of orthotopic lung transplantation: Scientific uses, tricks of the trade, and tips for success.Physician assistant model for lung procurements: a paradigm worth consideringThe role of bradykinin in lung ischemia-reperfusion injury in a rat lung transplantation model.Protein biomarkers associated with primary graft dysfunction following lung transplantation.Quantitative Evidence for Revising the Definition of Primary Graft Dysfunction After Lung Transplant.Receptor for advanced glycation end products in donor lungs is associated with primary graft dysfunction after lung transplantation.Lung-Restricted Antibodies Mediate Primary Graft Dysfunction and Prevent Allotolerance after Murine Lung Transplantation.Alcohol and the Lung.Integrative analysis correlates donor transcripts to recipient autoantibodies in primary graft dysfunction after lung transplantation.Venovenous ECMO as a bridge to lung transplant and a protective strategy for subsequent primary graft dysfunction.A randomized, placebo-controlled trial of aprotinin to reduce primary graft dysfunction following lung transplantation.Inhibiting Integrin αvβ5 Reduces Ischemia-Reperfusion Injury in an Orthotopic Lung Transplant Model in Mice.Alternative solution for ex vivo lung perfusion, experimental study on donated human lungs non-accepted for transplantation.Marker Games: Seeking Better Biomarkers?Lung transplantation from donors outside standard acceptability criteria--are they really marginal?Recipient vascular endothelial growth factor serum levels predict primary lung graft dysfunction.Impact of prolonged cold preservation on the graft function and gene expression levels in an experimental lung transplantation model.Historical perspectives of lung transplantation: connecting the dots
P2860
Q33653089-3821FFDB-B64E-48EC-B542-02B163CCA697Q33852943-8B59C3F2-AA73-4670-B5DA-C54315EA45E4Q34238666-15B360E9-FEFB-4481-8989-CBDEAB1D5D6EQ34532579-42DF555E-6FF0-4FC3-88CF-2D76A503E29EQ34764561-BB25A59F-B5E9-4594-8E12-A0DC6874DAD0Q34815331-90B837F3-BBD5-4926-A2F1-0F54ADF05BFCQ35033561-708D4F1D-3698-4A8B-88CB-566284BB45FAQ35153485-1AD25E52-FFF4-4BCB-BF39-A574E671B788Q35855114-C6EEF7FF-9BAA-4CEB-9F0D-0DC2FB7910BCQ36345294-4B1FB3F3-C9EA-4B8C-B383-5A74B278A308Q36768114-AAB3AC14-77D6-4A4F-B07B-3F55B1CA4365Q37071116-780FED04-D78C-49E6-A3BF-40299BABD17EQ37179142-CD3D271D-CCD3-4A84-B0C3-6B87E9782024Q37423137-5A58EAB0-9746-4207-9D51-A25A50598808Q37670609-23B02D65-906B-4740-9C0C-451B32A115AFQ37688473-8AA43E3F-DFF9-4308-99DA-1C09D2ABE1FBQ38023423-F1238B89-A173-4BF0-B7BE-9342F604540EQ38148817-BDFE16D8-349F-4412-AA34-6F8C7BC9ADDAQ39027003-58066211-078E-4210-B1D6-6C94B51EC7EEQ39107058-8D1797C7-5544-4ABE-AD41-AB4EC16A5E4EQ40057755-D5A0A9DF-659C-4138-887A-94BD9B5EA9ACQ40598542-6C3E5410-EC4B-4714-A9E2-E17643FF4717Q41631328-61A62A83-C499-4480-AA34-7AF802F03BDAQ42206174-87056C98-B45F-4369-8178-1DE464E4E215Q43872606-69C433C6-5DE5-4AC0-9483-FD5B78A9B86FQ45830805-F084BBA3-E368-43BD-A3EB-21EDD6E9BE5DQ46003287-5E540E86-8981-444E-A10F-E85A495AC284Q46725453-89F7DA83-A8CF-490A-A842-7777417EB79BQ48157703-1C0D2011-71B3-4B9D-8B87-2A933A312879Q48178212-9464758C-7836-4557-93B7-FF1A9C3E6A1EQ48632739-ACEE9981-46CD-4B62-BB54-56DB2B667711Q53242921-FE5339B6-E41A-4B11-BE3F-0750AF3CFEE6Q54279822-494C5D5C-735B-4DDC-80B5-96D00C2504C6Q57178578-51CD5716-0CB6-44AD-BA1C-319498C7577C
P2860
Report of the ISHLT Working Group on Primary Lung Graft Dysfunction part V: predictors and outcomes.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh
2005年學術文章
@zh-hant
name
Report of the ISHLT Working Gr ...... rt V: predictors and outcomes.
@ast
Report of the ISHLT Working Gr ...... rt V: predictors and outcomes.
@en
type
label
Report of the ISHLT Working Gr ...... rt V: predictors and outcomes.
@ast
Report of the ISHLT Working Gr ...... rt V: predictors and outcomes.
@en
prefLabel
Report of the ISHLT Working Gr ...... rt V: predictors and outcomes.
@ast
Report of the ISHLT Working Gr ...... rt V: predictors and outcomes.
@en
P2093
P1476
Report of the ISHLT Working Gr ...... rt V: predictors and outcomes.
@en
P2093
Andrew Fisher
ISHLT Working Group on Primary Lung Graft Dysfunction
Masina Scavuzzo
Ramsey R Hachem
Selim M Arcasoy
P304
P356
10.1016/J.HEALUN.2004.11.314
P577
2005-10-01T00:00:00Z